Apparatus and methods for treatment of arthrosis or osteoarthritis in a joint of a mammal or human patient

Patent metadata

Field	Value
Publication number	US-11752014-B2
Application number	US-202117167304-A
Country	US
Kind code	B2
Filing date	Feb 4, 2021
Priority date	Jul 10, 2009
Publication date	Sep 12, 2023
Grant date	Sep 12, 2023

Abstract

A proposed treatment of arthrosis/osteoarthritis in a joint of a mammal or human patient involves deposing a liquid material on at least one damaged surface of the joint. To accomplish this, a reservoir (110) is provided, which holds a volume of a biocompatible material in liquid form outside of a body containing the joint (J) to be treated. A proximal end (P) of a tube-shaped instrument (120) is connected to the reservoir (110), and a distal end (D) of the instrument (120) is inserted into the joint (J). The liquid material is fed through the instrument (120) to the distal end (D) for deposition on the at least one damaged joint surface.The material is configured to assume a solid form under predefined conditions (e.g. when cooling off, or being exposed to a specific type of radiation). When the material has the solid form, it has a resistance to wear adapted to replace a worn out joint surface.

First claim

The invention claimed is:

1. A method for treatment of arthrosis in a joint of a mammal or human patient, the method comprising:
feeding a volume of a biocompatible material in liquid form into a reservoir ( 110 ) located outside of a body containing a joint (J) to be treated,
inserting into the joint (J) an instrument ( 120 ) having a general tube shape, a distal end (D) of the instrument ( 120 ) being configured to be inserted into the joint (J), and a proximal end (P) of the instrument ( 120 ) being connected to the reservoir ( 110 ),
receiving the liquid material from the reservoir ( 110 ) in the instrument ( 120 ),
feeding the liquid material from the proximal end (P) to the distal end (D) of the instrument ( 120 ), and

deposing the material on at least one damaged surface (S) of the joint (J), the material being configured to assume a solid form under predefined conditions, and when in the solid form the material having a resistance to wear adapted to replace a worn out joint surface, wherein said biocompatible material has a temperature higher than 90° C. when entering the joint.

2. The method according to claim 1 , further comprising:
inserting a mould member ( 140 ) into the joint (J), the mould member ( 140 ) having a pre-produced shape adapted to a shape and size of at least one of the at least one damaged surface (S) so as contact and cover this surface (S) when placed in the joint (J), the mould member ( 140 ) being flexible, collapsible and having an internal volume configured to be filled with liquid material received via the instrument ( 120 ), the mould member ( 140 ) being connected to the distal end (D) of the instrument ( 120 ),
form-fitting the mould member ( 140 ) to said at least one damaged surface (S),
injecting the material into the mould member ( 140 ) through the instrument ( 120 ), receiving the material in the mould member ( 140 ), causing a transition of the material from the liquid form to the solid form after that the mould member ( 140 ) has been filled with the liquid material.

3. The method according to claim 2 , comprising pre-producing the mould member ( 140 ) according to a shape and size of at least one of the damaged surface (S) so as enable the mould member ( 140 ) to contact and cover the damaged surface (S) when placed in the joint (J).

4. The method according to claim 3 , comprising determining the shape and size of the at least one of the damaged surface (S) via a magnetic resonance imaging investigation, a computer tomography x-ray investigation or via arthroscopy.

5. The method according to claim 2 , comprising illuminating the joint (J) by means of a light source ( 130 ) during deposition of the liquid material on at least one damaged surface (S) of the joint (J).

6. The method according to claim 2 , wherein the biocompatible liquid material comprises fluoropolymers.

7. The method according to claim 6 , wherein the fluoropolymers comprises one of polytetrafluoroethylene, perfluoroalkoxy or fluorinated ethylene propylene.

8. The method according to claim 1 , wherein the biocompatible material comprises two components, each component when isolated from the other component being a liquid, the components when mixed in predefined proportions developing a solid material, the reservoir ( 110 ) being configured to hold the two components separated from one another, and the method comprising:
mixing the two components during surgery, and subsequently
feeding the mixed components through the instrument ( 120 ) to the at least one damaged joint surface (S).

9. The method according to claim 1 , wherein the biocompatible material is liquid when exposed to electromagnetic radiation in a predefined spectrum being below a first predefined energy level per unit volume, and the biocompatible material is a solid material when exposed to electromagnetic radiation in the predefined spectrum above a second predefined energy level per unit volume, and the method comprising irradiating the at least one damaged joint surface (S) with electromagnetic radiation in the predefined spectrum.

10. The method according to claim 1 , wherein the biocompatible material is liquid when exposed to ultrasonic energy in a predefined spectrum being below a primary predefined energy level per unit volume, and the biocompatible material is a solid material when exposed to ultrasonic energy in the predefined spectrum being above a secondary predefined energy level per unit volume, and the method comprising sending ultrasonic energy in the predefined spectrum to the at least one damaged joint.

11. The method according to claim 1 , comprising maintaining the biocompatible material sterile in the reservoir ( 110 ) and in a connection to the instrument ( 120 ).

12. The method according to claim 1 , comprising inserting the distal end (D) of the instrument ( 120 ) into the joint (J) via at least one bone ( 210 , 220 ) of the body.

13. The method according to claim 1 , comprising inserting the distal end (D) of the instrument ( 120 ) into a hip joint (J) by passing via a bone ( 220 ) of the body from inside the abdomen.

14. The method according to claim 1 , comprising inserting the distal end (D) of the instrument ( 210 ) into a hip joint (J) by passing via the femoral bone ( 210 ) of the body.

15. The method according to claim 1 , comprising inserting the distal end of the instrument ( 120 ) into the joint (J) by passing via a capsula of the joint (J).

16. The method according to claim 1 , comprising the biocompatible material at a temperature of at least 150 degrees Celsius in the reservoir ( 110 ), or of at least 200 degrees Celsius in the reservoir, or of at least 300 degrees Celsius in the reservoir, or of at least 400 degrees Celsius in the reservoir.

17. The method according to claim 1 , wherein said material comprises at least one material selected from the group consisting of:
polytetrafluoroethylene,
perfluoroalkoxy
fluorinated ethylene propylene,
polyethylene, and
acrylic polymer mixed with alumina trihydrate.

Assignees

• Forsell Peter

Inventors

• Forsell Peter

Classifications

• A61F2/4618 Primary

  of cartilage · CPC title

• A61B17/1666

  for the acetabulum · CPC title

• A61B17/1668

  for the upper femur (A61B17/164 takes precedence) · CPC title

• A61F2/30

  Joints · CPC title

• A61F2/30756

  Cartilage endoprostheses (A61F2/3603 takes precedence) · CPC title